Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
HitIQ Limited ( (AU:HIQ) ) has issued an announcement.
HitIQ Limited has launched a non-deal roadshow to update the market on its biosensor and intelligence platform, which provides objective impact measurement for sport, defence, insurance and other high-risk sectors. The company will hold investor and stakeholder meetings in Perth on 12 May, Melbourne on 15 May, Singapore on 4 June, and in the U.S. in June 2026, signalling an effort to broaden awareness of its technology and market positioning without raising capital or providing financial guidance.
The update, approved by the company’s chair, emphasises that the material is informational only and does not constitute an offer, prospectus or investment advice, underscoring a cautious approach to regulatory and disclosure obligations. By framing the document strictly as a strategic and positioning overview, HitIQ appears focused on educating the market and potential partners about its impact-measurement capabilities while managing expectations around near-term financial commitments.
More about HitIQ Limited
HitIQ Limited is an Australian technology company listed on the ASX that develops a biosensor and intelligence platform focused on objective impact measurement. Its products are targeted at sports, defence, insurance and other high‑risk environments where tracking and analysing physical impacts can improve safety and risk management.
Average Trading Volume: 356,628
Technical Sentiment Signal: Sell
Current Market Cap: A$9.07M
See more insights into HIQ stock on TipRanks’ Stock Analysis page.